Antibody to Optic atrophy 1. Clone 1OPA-1A8 detects six OPA1 protein isoforms in mouse and human tissues.
| Institute |
|---|
| Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) |
| Cat. #: | 162422 |
|---|---|
| Research Fields: | Metabolism |
| Application: | ELISA, WB, IF, immunoprecipitation |
| Target: | OPA1 |
| Reactivity: | Human, mouse |
| Clone: | OPA-1A8 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Akepati et al., (2008) J Neurochem. 106(1): 372-83. PMID: 18419770 |
| Product description: | Antibody to Optic atrophy 1. Clone 1OPA-1A8 detects six OPA1 protein isoforms in mouse and human tissues. |
|---|---|
| Additional notes: | Avoid repeat freezing and thawing cycles. Does not contain any preservative. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1, k |
| Immunogen: | mouse OPA1 fragment from aa 111 to 960 as a fusion protein. |
| Target background: | Optic atrophy 1 is a dynamin-related GTPase involved in mitochondrial fusion, and its altered expression can affect cellular metabolism and apoptosis in cancer. |
|---|
| Storage conditions: | -20°C (up to 3 years) |
|---|
| References: |
Akepati et al., (2008) J Neurochem. 106(1): 372-83, PMID: 18419770 |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151026 | Anti-FCGR1 [10.1] mAb |
Key Info
Anti-FCGR1 [10.1] mAb
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.